ReWalk Stock Triples as Robotic Suit for Stroke Victims Gets FDA Nod

(Bloomberg) -- Shares of ReWalk Robotics Ltd. tripled after the Food and Drug Administration said the small-cap device company could start selling its ReStore soft exoskeleton-suit system.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.